Your browser doesn't support javascript.
loading
Selective elimination of immunosuppressive T cells in patients with multiple myeloma.
Awwad, Mohamed H S; Mahmoud, Abdelrahman; Bruns, Heiko; Echchannaoui, Hakim; Kriegsmann, Katharina; Lutz, Raphael; Raab, Marc S; Bertsch, Uta; Munder, Markus; Jauch, Anna; Weisel, Katja; Maier, Bettina; Weinhold, Niels; Salwender, Hans Jürgen; Eckstein, Volker; Hänel, Mathias; Fenk, Roland; Dürig, Jan; Brors, Benedikt; Benner, Axel; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael.
Afiliação
  • Awwad MHS; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Mahmoud A; Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
  • Bruns H; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Echchannaoui H; Department of Hematology and Oncology, Erlangen University Hospital, Erlangen, Germany.
  • Kriegsmann K; Third Department of Medicine, University Cancer Center (UCT), University Medical Center (UMC) of the Johannes Gutenberg University, Erlangen, Germany.
  • Lutz R; German Cancer Consortium (Dktk), Partner Site Frankfurt/Mainz, Mainz, Germany.
  • Raab MS; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Bertsch U; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Munder M; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Jauch A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center and Department of Internal Medicine V, University of Heidelberg, 69120, Heidelberg, Germany.
  • Weisel K; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Maier B; National Center for Tumor Diseases, Heidelberg University, Heidelberg, Germany.
  • Weinhold N; Third Department of Medicine, University Cancer Center (UCT), University Medical Center (UMC) of the Johannes Gutenberg University, Erlangen, Germany.
  • Salwender HJ; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.
  • Eckstein V; Department of Oncology, Hematology and BMT, University Medical Center of Hamburg-Eppendorf, Hamburg, Germany.
  • Hänel M; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Fenk R; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Dürig J; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.
  • Brors B; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Benner A; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Müller-Tidow C; Department of Hematology, Oncology and Clinical Immunology, Düsseldorf University, Hamburg, Germany.
  • Goldschmidt H; Department of Hematology, Essen University, Hamburg, Germany.
  • Hundemer M; Division of Applied Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
Leukemia ; 35(9): 2602-2615, 2021 09.
Article em En | MEDLINE | ID: mdl-33597728
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depleção Linfocítica / Anticorpos Monoclonais Humanizados / Família de Moléculas de Sinalização da Ativação Linfocitária / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depleção Linfocítica / Anticorpos Monoclonais Humanizados / Família de Moléculas de Sinalização da Ativação Linfocitária / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha